Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3788327 A
Publication typeGrant
Publication dateJan 29, 1974
Filing dateMar 30, 1971
Priority dateMar 30, 1971
Publication numberUS 3788327 A, US 3788327A, US-A-3788327, US3788327 A, US3788327A
InventorsDonowitz H
Original AssigneeDonowitz H, Hara W
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Surgical implant device
US 3788327 A
Abstract
Disclosed implant device includes a valve and conduit means for controlling the intra-occular pressure build up in a diseased eye.
Images(1)
Previous page
Next page
Description  (OCR text may contain errors)

United States Patent [1 1 Donowitz et a1.

[ Jan. 29, 1974 SURGICAL IMPLANT DEVICE [76] Inventors: Howard Donowitz, Box 218, R.D.

No. 1; William J. OHara, 23 Hampton Dr., both of Freehold, NJ. 07728 [22] Filed: Mar. 30, 1971 [21] Appl. No.: 129,384

[52] U.S. Cl 128/350 R [51] Int. Cl. A61m 27/00, A61m 25/00 [58] Field of Search 128/348, 350 R, 350 V [56] References Cited UNITED STATES PATENTS 2,867,213 1/1959 Thomas, Jr. 128/350 V 3,333,588 8/1967 Schulte 128/350 R 274,447 3/1883 Kennish 128/348 UX 733,152 7/1903 Chisholm 128/350 V 1,388,172 8/1921 Craddock 128/348 3,159,161 12/1964 Ness 128/350 R 3,421,509 1/1969 Fiore 128/349 R 6/1856 Peale 3/D1G. 3

OTHER PUBLICATIONS Teflon Armstrong Beveled Drain Tube, Advertisement of Richards Mfg. Co., Memphis, Tenn. Copyright Primary Examiner-Channing L. Pace Attorney, Agent, or Firm-Leonard R. Fellen ABSTRACT Disclosed implant device includes a valve and conduit means for controlling the intra-occular pressure build up in a diseased eye.

7 Claims, 6 Drawing Figures PATENTED JAN29 I974 INVENTORS HOWARD DONPWITZ O,E' WILLIAM J. OHARA ATTORNEY SURGICAL IMPLANT DEVICE This invention relates generally to surgical devices and more particularly to a surgical device to be implanted in an eye for controlling intra-occular pressure, as, for example, in a glaucoma diseased eye wherein there is an increased pressure built up within the eye from the accumulation of fluid.

Normally, fluid called aqueous humor, which constantly forms and enters portions of the eye globe known as the anterior and posterior chambers, are balanced by those fluids which leave the eye by drainage through the canal of Schlemm. In glaucoma, for example, more fluid is secreted than is discharged, which results in an increase in intra-occular pressure, causing pain, interference with vision, and eventual blindness. In acute and chronic cases of glaucoma, this fluid imbalance is usually due to a blockage of the canal of Schlemm from a change in the character of the filtering or drainage tissues or a collapse of the angle of the anterior chamber.

Many surgical procedures for treating acute and chronic glaucoma and involving incisions and device implants have been proposed or tried, all of which has met with rather varied and inconsistent results. One such device includes, for example, an elongated tubular section curved to the same radius as an eye and an attached right angled section including a bore and adapted for insertion into a hole surgically drilled in an eye so as to provide for the drainage of fluid through the device into the retrobulbar space behind the eye.

Particular problems and disadvantages apparent in this and other prior art devices are the general lack of any provisions in the devices to safeguard against excessive drainage of fluid which could bring about a collapse of the anterior chamber causing a possible loss of sight or the eye itself. The drilling of a hole, for example, for receiving the right angled section for the abovedescribed device may in itself cause an excessive loss of fluid. Also, devices of the type including an extended bore or continuous open channel for fluid drainage also provide a means for the outside entry of harmful bacteria into the anterior chamber, with a possible resulting infection of the eye.

It is an object of the present invention to provide an implant device which is simple in construction, free of the aforementioned disadvantages and effective in controlling excessive intra-occular pressure.

It is another object of the present invention to provide a device which when surgically implanted in a glaucomatic eye operates in a manner to relieve an excessive intra-occular pressure.

It is another object of the present invention to provide a device which when implanted in a glaucoma diseased eye serves as a drain for excess fluid built up in the anterior and posterior chambers.

Briefly described, the implant device of the present invention includes an elongated shank member have a passageway axially extending therethrough and mounting a valve therein to normally provide for closure of the passageway, the valve opening in response to a predetermined pressure differential within the passageway. A flange is provided on one end of the shank member to anchor the implant device. Means are also provided on the shank member for insuring retention of the device in the eye.

The novel features which are considered to be characteristic of the invention are set forth with particularity in the appended claims. The invention itself, however, both as to its organization and method of operation as well as additional objects and advantages thereof, will best be understood from the following description when read in connection with the accompanying drawing in which:

FIG. 1 is a vertical section of a human eye showing the device of the present invention implanted therein;

FIG. 2 is a perspective view of the implant device of the invention;

FIG. 3 is a top view of the device of FIG. 2;

FIG. 4 is an enlarged front sectional view taken along the lines 4-4 of FIG. 3;

FIG. 5 is an enlarged section of the valve area shown in FIG. 4; and

FIG. 6 is a modified front sectional view of the flange and upper shank portion of the device.

Referring now to the drawing, and to FIG. 1 thereof, there is illustrated a human eyeball which includes the lens 10, posterior chamber 12, anterior chamber 14, iris 16, sclera 18, canal of Schlemm 20, cornea 22, and the conjunctiva 24 of the eye. As shown in the Figure, the device 26 of the present invention when implanted in the eye preferably extends through the cornea 22 and into the anterior chamber 14 of the eye.

With reference particularly now to FIGS. 2, 3, 4 and 5 in the drawing, a preferred embodiment of an implant device in accordance with the present invention comprises an elongated body or shank portion 28 generally cylindrical in shape, slightly tapered, and having a bore or passageway 30 extending axially therethrough. One end 32 of the shank portion 28 is capped by an integrally formed circular flange 34 with the passageway opening therethrough. The other end of the passageway opens through the bottom portion 36 of the shank 28 which has an obliquely slanted end face 38 to facilitate implantation of the device 26 into an eye as will hereinafter be described.

As shown particularly in FIG. 4, the flange portion 34 is preferably slanted or obliquely positioned relative to the longitudinal axis of the shank portion and has its top and bottom surfaces 40 and 42 arcuately contoured so as to conform generally to the cornea or other portion of the eyeball surface into which the device is to be implanted. The flange portion 34 being seated thereon thus serves to prevent the implant device from being submerged into the eye after insertion.

In spaced array along the periphery of the flange portion 34 are a plurality of apertures 44. Spaced downwardly from the flange portion 34 and extending up and outwardly from the outside surface of the shank portion 28 are a pair of integrally formed projections or barbs 46 which may serve as a means for retaining the device in the eye after implantation. It is important that the barbs 46 be spaced sufficiently beneath the underside of the flange so as to accommodate therebetween the wall thickness of the cornea or other portion of the eyeball receiving the implant device, or alternately be spaced so as to lock within the stroma or mid point of the cornea.

In accordance with the invention, a valve means 48 is provided and seated within the shank passageway 30 so as to normally provide for a closure of the passageway, and for opening in response to a predetermined pressure differential within the passageway and on opposing portions of the valve means.

More particularly, and as shown in FIG. 5, a preferred valve means includes a pair of opposing flexible web or reed-like members 50 and 52 formed integral with and extending out from the inside wall surfaces bounding the passageway 30 and normally abutting one another so as to close off the passageway and inhibit any flow therethrough. Preferably the valve is formed in the shank portion at a point intermediate the ends thereof. The abutting engagement of the reed members 50 and 52 is such that the valve functions in a one-way manner by allowing for the upward deflection of the reed members 50 and 52 in response to the presence of a predetermined increase in pressure exerted on the bottom surfaces 54 and 56 (as viewed in the Figures) of the reed members relative to the pressure exerted on the top surfaces 58 and 60 of the reed members.

It will be appreciated that in fabricating the: device of the invention, the material chosen must be inert and nontoxic. Also it is desirable that the material be somewhat resilient so as to allow for an integral formation within the internal passageway of a one-way valve. One material that has proved satisfactory for this purpose is manufactured by the DuPont Company, under the trade name Teflon. The double reed valve may be fabricated, for example, by machining the shank portion bore from both ends to provide a diaphragm like membrane between the bored end portions. The membrane is then pierced to create a double reed type valve. Piercing of the membrane is from the bottom end of the bore such that the reed valve operates to open only toward the top or flange end of the shank, thereby functioning as a one-way type valve. The valve is thus dependent on the memory retention or resiliency of the material of which it is formed, in addition to the back pressure exerted on the flange side of the valve, to return to its seat or closed position.

It should be noted that the pressure differential or program setting to which the valve openly responds is determined by the thickness of the membrane forming the reed members, the general characteristics and resiliency of the material used in fabricating the device as well as the size of the bore opening or passageway.

Advantages in the use of a double reed type valve are the relative ease with which the response threshold point of the valve can be controlled, i.e., the point at which the valve responds to a pressure difference. Also the greater the pressure difference, the more the valve flaps or reed members will deflect to open the passageway and allow for fluid discharge, the valve opening being directly proportional to the applied pressure differential.

It will be also be apparent that other types of valve means, as, for example, a ball valve, single reed valve or a spring valve may be used in the construction of the device of the present invention.

Insertion and operation of the implant device into an eye will now be described.

As shown in FIG. 1, the device of the present invention may be implanted into and through the cornea 22 and into communication with the anterior chamber 14, the implantation preferably being made in the upper portion of the cornea just beneath the canal of Schlemm 20.

As was heretofore noted, the shank portion of the implant device is preferably provided with a tapered outside contour as shown in the Figures so as to facilitate easy insertion, either directly or through a prepared tract into the eye. When insertion of the implant device is to be in the cornea, for example, a hyperdermic needle-like instrument is preferably used to first pierce the cornea to provide a tract for receiving the device. The cornea is a desirable area of the eye for receiving the device since the inherent pliable nature of the cornea will permit the easy implantation of the device and also enhance a sealing around the shank portion of the device after it is received in the eye. Also, in piercing the cornea to provide the receiving tract for the implant device, there is substantially no tissue or fluid loss.

It will be understood that the device can be inserted directly into the cornea without the aid of a tract. Also, other areas of the eyeball may be used for implantation of the device of the present invention.

Upon implantation, the device flange portion 34 will seat on the cornea or other area of the eye receiving the device, while the barb projections 46 lock against the underside of the receiving tissue for retaining the device in the eye. Altemately, the barb projections may be spaced so as to lock within the stroma of the cornea, or mid area of the receiving tissue.

As was heretofore noted, the flange portion 34 of the implant device may be provided with a plurality of apertures 44 spaced around the periphery thereof. These flange apertures 44 may serve two functions. When the device is implanted in the cornea portion of the eye, the apertures allow the eye tears to wash and provide for the normal irrigation of the cornea area under the flange. Where the implant is in another area of the eye, as, for example, through the sclera, the flange apertures may be used to anchor the device in the eye with the aid of sutures.

Initially the pressure of the top surfaces 58 and 60 of the valve, i.e., the discharge end of the valve, which is exposed to the outside of the eye after implantation of the device, is at or about the atmospheric pressure. Normally, the pressure inside the eye globe, and more particularly in the anterior and posterior chambers thereof is understood to be between 15 and 25 millimeters (mm.) of mercury above the atmospheric pressure. With the occurrence of an abnormal intra-occular build up of pressure inside the eye and again particularly in the anterior chamber which after insertion of the device is effectively in communication with the bottom surfaces 54 and 56 of the reed members, i.e., the intake end of the valve, a point is reached, i.e., the threshold or program setting of the valve, wherein the valve will open to allow the passage of fluid from the anterior chamber through the shank bore of passageway to the outside of the eye wherein it mingles with existing eye tears and is disposed of in the normal manner. The increased intra-occular pressure built up is in this way controlled. The pressure point at which the valve may be programmed to open may, for example, be between 20 and 25 mm. of mercury.

When the pressure difference on both sides of the valve membrane, i.e., the top and bottom surfaces of the reed members, decreases to a preset level substantially equal to the aforementioned program setting, the valve closes. The rate and degree of valve opening is a function of the amount of the intra-occular pressure and consequently the pressures exerted on the bottom surfaces of the valve reed members. The valve serves to regulate the flow of fluid through the shank passageway in direct proportion to the degree of excessive intra-occular pressure built up in the eye. Since the intraoccular pressure will be changing as the valve allows for the discharge of fluid, the valve reeds will tend to substantially open and close or flutter in operation.

Since the cornea does not have blood vessels or a blood supply, by this fluttering action of the valve, the circulation of the aqueous is enhanced against the posterior part of the cornea. This is desirable since the aqueous normally provides a means of carrying nourishment to the cornea and also for the disposal of waste matter.

It should be noted that another advantage inherent in the implant device of the present invention is its minute size. A device in accordance with the invention has been constructed with an operating valve as abovedescribed and with a shank length of approxiamtely 2.5 mm., a bore diameter of approximately 0.5 mm., and a flange portion 2 mm. in diameter.

It will be appreciated that the relatively small size of the device will minimize friction between an eyelid and the device when implanted. Also, during implantation of the device and because of its size, there will be substantially no tissue of fluid loss.

Turning now to FIG. 6, there is illustrated a fragmentary sectional view showing a modified embodiment of the flange and retaining means portons of the implant device of the present invention.

More particularly, the upper end of the shank portion 28 is necked down as shown so as to provide a step or shelf 62 which functions to help retain the implant device in an eye in a manner similar to that of the heretofore described barb projections shown in FIG. 4. The top surface 40 of the flange portion 34 is provided with an integrally formed annular rib or ridge member 64. With the device implanted in an area of the eye other than the cornea, and more particularly the sclera, the ridge 64 will serve to discourage the formation of cicatrix or scar tissue over the flange opening of the passageway.

It will thus be seen that the device herein described may be easily implanted in a human eye, provides a minimum of discomfort to the recipient, and functions in a simple, eyt effective manner to control an intraoccular pressure build up. It will also be clear that variations in the details of consruction which are specifically illustrated and described may be resorted to without departing from the scope of the invention.

What is claimed is:

1. A surgical implant device for implantation in an eye comprising:

an elongated shank member generally tubular in shape and having a flange surrounding one end thereof, said shank member being provided with a passageway opening in said one end through said flange and axially extending through said shank and out the other end thereof;

valve means seated within said passageway and normally positioned to provide for closure thereof, said valve means opening in response to a predetermined pressure differential within said passageway and on opposing sides of the valve; and

means integrally formed on and disposed along said shank member axially spaced from said flange for the retention of said device in an eye; said flange being in an inclined position relative to the axis of said shank member and the side of said flange from which the shank extends being arcuately contoured to conform generally to the surface of a human eye. 2. A device as defined in claim 1 wherein said retention means includes a plurality of spaced projections formed on the outside surface of said shank member and angled upwardly toward said flange portion.

3. A device as defined in claim 1 wherein a first portion of said shank member depends from said flange portion and is necked down to form a step with the remaining portion thereof, the remaining portion of said shank member thereafter tapering toward said botton end.

4. A device as defined in claim 1 wherein said flange includes a ridge member integrally formed on the surface thereof opposite said shank and concentric with the opening therein,

5. A device as defined in claim 1 wherein said valve means includes a pair of opposing reed members integrally formed within said passageway and extending thereacross so as to normally close off said passageway. 6. A device as defined in claim 5 wherein said flange includes a plurality of openings spaced around the periphery thereof.

7. A surgical device for implantation in an eye comprising:

a flange portion having top and bottom surfaces and a central aperture therein;

an elongated body portion integral with said flange portion and depending from the bottom surface thereof, said body portion having an internal passageway continuous with said flange opening and extending lengthwise through said body portion to an axially in-line opening at the other end thereof;

pressure sensitive valve means seated within said passageway and normally positioned to provide for closure of said passageway, said valve means opening in response to a predetermined pressure differential within said passageway and on opposing sides of the valve;

said flange portion being generally circular in shape and overlying said body portion in an inclined position relative to the longitudinal axis of said body portion, said flange including a plurality of apertures spaced along the periphery thereof; and means integrally formed on and displaced along said body portion beneath said flange portion for the retention of said device in an eye, said retention means including a plurality of spaced projections formed along the outside surface of said body portion and angled upwardly toward said flange portion.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US15192 *Jun 24, 1856 Tubular
US274447 *Jan 19, 1881Mar 20, 1883 William-kentish
US733152 *Aug 30, 1902Jul 7, 1903Murdoch ChisholmEmpyema drainage device.
US1388172 *Mar 18, 1920Aug 23, 1921Craddock Simon MVeterinary surgical appliance
US2867213 *Jun 12, 1957Jan 6, 1959Jr Paul A ThomasFlutter valve for drainage of the pleural cavity
US3159161 *Nov 14, 1962Dec 1, 1964Alton Ness RichardFistulizing canaliculus
US3333588 *Jul 6, 1964Aug 1, 1967Schulte Rudolf RBrain ventricle cannula
US3421509 *Dec 17, 1965Jan 14, 1969John M FioreUrethral catheter
Non-Patent Citations
Reference
1 *Ellis, R. A. Reduction of Intraocular Pressure Using Plastics in Surgery , in Amer. Jour. Ophthal., 50: 733 742, 1960.
2 *Ore, Svein et al., Preparation of Surgical Implants From Silicone Rubber by Means of a Postforming Technique. Surgery, pp. 385 390, Aug. 1962.
3 *Teflon Armstrong Beveled Drain Tube, Advertisement of Richards Mfg. Co., Memphis, Tenn. Copyright 1966.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3890976 *Jan 21, 1974Jun 24, 1975Medical Products CorpCatheter tip assembly
US3915172 *Mar 26, 1973Oct 28, 1975Ceskoslovenska Akademie VedCapillary drain for glaucoma
US3938529 *Jul 22, 1974Feb 17, 1976Gibbons Robert PIndwelling ureteral catheter
US4037604 *Jan 5, 1976Jul 26, 1977Newkirk John BArtifical biological drainage device
US4175563 *Oct 5, 1977Nov 27, 1979Arenberg Irving KBiological drainage shunt
US4402681 *Sep 10, 1981Sep 6, 1983Haas Joseph SArtificial implant valve for the regulation of intraocular pressure
US4474569 *Jun 28, 1982Oct 2, 1984Denver Surgical Developments, Inc.For implantation inutero in a fetus by a thin-hollow surgical needle
US4521210 *Dec 27, 1982Jun 4, 1985Wong Vernon GEye implant for relieving glaucoma, and device and method for use therewith
US4554918 *Jul 28, 1982Nov 26, 1985White Thomas COcular pressure relief device
US4587954 *Jan 27, 1984May 13, 1986Habley Medical Technology CorporationElastomeric prosthetic sphincter
US4604087 *Jun 21, 1985Aug 5, 1986Joseph Neil HAqueous humor drainage device
US4645493 *Oct 21, 1985Feb 24, 1987N.U.S. S.R.L.Catheter for medical-surgical application
US4722724 *Jun 23, 1986Feb 2, 1988Stanley SchocketAnterior chamber tube shunt to an encircling band, and related surgical procedure
US4781675 *Aug 27, 1987Nov 1, 1988White Thomas CInfusion cannula
US4808183 *Jun 3, 1980Feb 28, 1989University Of Iowa Research FoundationVoice button prosthesis and method for installing same
US4813941 *Sep 3, 1987Mar 21, 1989Leslie SheaPneumothorax treatment device
US4826478 *Aug 21, 1987May 2, 1989Stanley SchocketAnterior chamber tube shunt to an encircling band, and related surgical procedure
US4886488 *Aug 4, 1988Dec 12, 1989White Thomas CGlaucoma drainage the lacrimal system and method
US4936825 *Apr 11, 1988Jun 26, 1990Ungerleider Bruce AMethod for reducing intraocular pressure caused by glaucoma
US4968296 *Dec 20, 1989Nov 6, 1990Robert RitchTransscleral drainage implant device for the treatment of glaucoma
US5064417 *Oct 11, 1989Nov 12, 1991Co Pharma Corporation S.R.L.Device for fastening a catheter to a cranial theca for performing cerebro spinal fluid drainage to the outside operations
US5092837 *Aug 27, 1990Mar 3, 1992Robert RitchMethod for the treatment of glaucoma
US5098393 *May 31, 1988Mar 24, 1992Kurt AmplatzMedical introducer and valve assembly
US5171213 *Aug 14, 1991Dec 15, 1992Price Jr Francis WFor relieving intraocular pressure from within the eye
US5178604 *May 31, 1990Jan 12, 1993Iovision, Inc.Glaucoma implant
US5207660 *Apr 26, 1991May 4, 1993Cornell Research Foundation, Inc.Method for the delivery of compositions to the ocular tissues
US5221278 *Mar 12, 1992Jun 22, 1993Alza CorporationOsmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5318558 *Dec 1, 1992Jun 7, 1994Alza CorporationOsmotically driven delivery device with expandable orifice for pulsatile delivery effect
US5372577 *Feb 18, 1993Dec 13, 1994Ungerleider; Bruce A.Apparatus for reducing intraocular pressure
US5397300 *Apr 21, 1994Mar 14, 1995Iovision, Inc.Glaucoma implant
US5476445 *Aug 1, 1994Dec 19, 1995Iovision, Inc.Glaucoma implant with a temporary flow restricting seal
US5558629 *Jul 21, 1992Sep 24, 1996Iovision, Inc.For draining fluid from an eye
US5626558 *May 5, 1995May 6, 1997Suson; JohnFor draining aqueous humor from an eye
US5626559 *May 1, 1995May 6, 1997Ramot University Authority For Applied Research And Industrial Development Ltd.Ophthalmic device for draining excess intraocular fluid
US5660205 *Dec 15, 1994Aug 26, 1997Epstein; Alan B.One-way valve
US5702414 *Sep 5, 1996Dec 30, 1997Optonol LtdMethod of implanting an intraocular implant
US5769093 *May 15, 1997Jun 23, 1998Xomed Surgical Products, Inc.In a capsule surrounding a joint
US5807303 *May 13, 1997Sep 15, 1998Xomed Surgical Products, Inc.Valve assembly and device for relieving synovial fluid pressure
US5968058 *Jul 14, 1997Oct 19, 1999Optonol Ltd.Device for and method of implanting an intraocular implant
US5971967 *Aug 19, 1997Oct 26, 1999Abbeymoor Medical, Inc.Urethral device with anchoring system
US6004302 *Aug 28, 1997Dec 21, 1999Brierley; Lawrence A.Cannula
US6050970 *May 8, 1997Apr 18, 2000Pharmacia & Upjohn CompanyMethod and apparatus for inserting a glaucoma implant in an anterior and posterior segment of the eye
US6203513Nov 20, 1997Mar 20, 2001Optonol Ltd.Flow regulating implant, method of manufacture, and delivery device
US6221060Oct 4, 1999Apr 24, 2001Abbeymoor Medical, Inc.Urethral device with anchoring system
US6258060Jun 30, 1999Jul 10, 2001Abbeymoon Medical, Inc.Urethral apparatus with position indicator and methods of use thereof
US6293951 *Aug 24, 1999Sep 25, 2001Spiration, Inc.Lung reduction device, system, and method
US6450984Apr 26, 2000Sep 17, 2002Gmp Vision Solutions, Inc.Shunt device and method for treating glaucoma
US6464724Apr 26, 2000Oct 15, 2002Gmp Vision Solutions, Inc.Stent device and method for treating glaucoma
US6468283 *Aug 26, 1999Oct 22, 2002Optonol, Ltd.Method of regulating pressure with an intraocular implant
US6508779Jan 24, 1997Jan 21, 2003John SusonAdjustable flow rate glaucoma shunt and method of using same
US6510600Dec 4, 2000Jan 28, 2003Optonol, Ltd.Method for manufacturing a flow regulating implant
US6544249Nov 28, 1997Apr 8, 2003The Lions Eye Institute Of Western Australia IncorporatedBiological microfistula tube and implantation method and apparatus
US6558342Jun 2, 1999May 6, 2003Optonol Ltd.Flow control device, introducer and method of implanting
US6595945 *Jan 9, 2001Jul 22, 2003J. David BrownGlaucoma treatment device and method
US6626858Sep 12, 2002Sep 30, 2003Gmp Vision Solutions, Inc.Shunt device and method for treating glaucoma
US6632243Sep 16, 1999Oct 14, 2003Emphasys Medical Inc.Body fluid flow control device
US6666841May 2, 2001Dec 23, 2003Glaukos CorporationBifurcatable trabecular shunt for glaucoma treatment
US6679264Mar 4, 2000Jan 20, 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6692455Dec 28, 2001Feb 17, 2004Medtronic Xomed, Inc.Composite ventilation tube
US6694979Mar 2, 2001Feb 24, 2004Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6726664Aug 6, 2001Apr 27, 2004Optonol Ltd.Flow control device, introducer and method of implanting
US6730056 *Sep 21, 2000May 4, 2004Motorola, Inc.Eye implant for treating glaucoma and method for manufacturing same
US6736791Nov 1, 2000May 18, 2004Glaukos CorporationGlaucoma treatment device
US6780164Mar 21, 2003Aug 24, 2004Glaukos CorporationL-shaped implant with bi-directional flow
US6783544Oct 11, 2002Aug 31, 2004Gmp Vision Solutions, Inc.Stent device and method for treating glaucoma
US6827699May 27, 2003Dec 7, 2004Gmp Vision Solutions, Inc.Shunt device and method for treating glaucoma
US6827700May 27, 2003Dec 7, 2004Gmp Vision Solutions, Inc.Shunt device and method for treating glaucoma
US6840243 *Apr 18, 2003Jan 11, 2005Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6881198Jun 16, 2003Apr 19, 2005J. David BrownGlaucoma treatment device and method
US6901927Nov 22, 2002Jun 7, 2005Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6904909Nov 22, 2002Jun 14, 2005Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US6929637Dec 11, 2002Aug 16, 2005Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US6936023Oct 10, 2003Aug 30, 2005Medtronic Xomed, Inc.Composite ventilation tube
US6939494Dec 28, 2001Sep 6, 2005Medtronic Xomed, Inc.Method of making ventilation tube
US6941950Oct 10, 2002Sep 13, 2005Emphasys Medical, Inc.Bronchial flow control devices and methods of use
US6955656Dec 4, 2002Oct 18, 2005Glaukos CorporationApparatus and method for treating glaucoma
US6966888 *Jan 13, 2002Nov 22, 2005Eagle Vision, Inc.Sinus valved glaucoma shunt
US6981958Jul 24, 2003Jan 3, 2006Glaukos CorporationImplant with pressure sensor for glaucoma treatment
US7011094Jul 25, 2003Mar 14, 2006Emphasys Medical, Inc.Bronchial flow control devices and methods of use
US7033387Apr 18, 2003Apr 25, 2006Emphasys Medical, Inc.Body fluid flow control device
US7094225May 3, 2002Aug 22, 2006Glaukos CorporationMedical device and methods of use of glaucoma treatment
US7100616Apr 8, 2003Sep 5, 2006Spiration, Inc.Bronchoscopic lung volume reduction method
US7135009Apr 8, 2002Nov 14, 2006Glaukos CorporationGlaucoma stent and methods thereof for glaucoma treatment
US7163543Jun 7, 2002Jan 16, 2007Glaukos CorporationCombined treatment for cataract and glaucoma treatment
US7165548Jul 29, 2003Jan 23, 2007Emphasys Medical, Inc.Methods and devices for use in performing pulmonary procedures
US7186232Mar 7, 2003Mar 6, 2007Glaukoa CorporationFluid infusion methods for glaucoma treatment
US7195646 *Oct 28, 2002Mar 27, 2007Oded NahleiliPolymeric stent useful for the treatment of the salivary gland ducts and method for using the same
US7220238 *Jul 27, 2004May 22, 2007Gmp Vision Solutions, Inc.Shunt device and method for treating glaucoma
US7226540Aug 4, 2004Jun 5, 2007Becton, Dickinson And CompanyMEMS filter module
US7273475Oct 21, 2005Sep 25, 2007Glaukos CorporationMedical device and methods of use for glaucoma treatment
US7276077Jun 3, 2003Oct 2, 2007Emphasys Medical, Inc.Body fluid flow control device
US7291125Nov 14, 2003Nov 6, 2007Transcend Medical, Inc.Ocular pressure regulation
US7297130Mar 21, 2003Nov 20, 2007Glaukos CorporationImplant with anchor
US7331984Aug 28, 2002Feb 19, 2008Glaukos CorporationGlaucoma stent for treating glaucoma and methods of use
US7354416 *Feb 18, 2004Apr 8, 2008Hugo Quiroz-MercadoMethods and devices for draining fluids and lowering intraocular pressure
US7364564Dec 24, 2004Apr 29, 2008Becton, Dickinson And CompanyImplant having MEMS flow module with movable, flow-controlling baffle
US7384550Feb 24, 2005Jun 10, 2008Becton, Dickinson And CompanyGlaucoma implant having MEMS filter module
US7412977Mar 6, 2003Aug 19, 2008Emphasys Medical, Inc.Methods and devices for inducing collapse in lung regions fed by collateral pathways
US7431710Mar 18, 2005Oct 7, 2008Glaukos CorporationOcular implants with anchors and methods thereof
US7434578Dec 22, 2003Oct 14, 2008Spiration, Inc.Methods of achieving lung volume reduction with removable anchored devices
US7476203Oct 26, 2005Jan 13, 2009Spiration, Inc.Device and method for measuring the diameter of an air passageway
US7481816 *Oct 27, 2003Jan 27, 2009Optonol Ltd.Intraocular implant, delivery device, and method of implantation
US7488303Sep 22, 2003Feb 10, 2009Glaukos CorporationOcular implant with anchor and multiple openings
US7507258Mar 5, 2007Mar 24, 2009Oded NahleiliPolymeric stent useful for the treatment of the salivary gland ducts and method for using the same
US7533671Dec 22, 2003May 19, 2009Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US7544176Jun 21, 2005Jun 9, 2009Becton, Dickinson And CompanyGlaucoma implant having MEMS flow module with flexing diaphragm for pressure regulation
US7563241Nov 13, 2006Jul 21, 2009Glaukos CorporationImplant and methods thereof for treatment of ocular disorders
US7662181Mar 30, 2006Feb 16, 2010Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US7670310Dec 7, 2007Mar 2, 2010Optonol LtdFlow regulating implants
US7670373Mar 3, 1998Mar 2, 2010Pulmonx CorporationOcclusion device
US7678065Sep 24, 2004Mar 16, 2010Glaukos CorporationImplant with intraocular pressure sensor for glaucoma treatment
US7708711Nov 12, 2003May 4, 2010Glaukos CorporationOcular implant with therapeutic agents and methods thereof
US7717115Nov 25, 2003May 18, 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US7757692Apr 22, 2009Jul 20, 2010Spiration, Inc.Removable lung reduction devices, systems, and methods
US7771472Nov 18, 2005Aug 10, 2010Pulmonx CorporationBronchial flow control devices and methods of use
US7798147Jul 25, 2003Sep 21, 2010Pulmonx CorporationBronchial flow control devices with membrane seal
US7814912Jun 29, 2005Oct 19, 2010Pulmonx CorporationDelivery methods and devices for implantable bronchial isolation devices
US7815592Apr 22, 2008Oct 19, 2010Transcend Medical, Inc.Ocular pressure regulation
US7842061Dec 23, 2003Nov 30, 2010Spiration, Inc.Methods of achieving lung volume reduction with removable anchored devices
US7850637 *Nov 12, 2004Dec 14, 2010Glaukos CorporationShunt device and method for treating glaucoma
US7850638Dec 22, 2006Dec 14, 2010Transcend Medical, Inc.Ocular pressure regulation
US7854228Mar 28, 2005Dec 21, 2010Pulmonx CorporationBronchial flow control devices and methods of use
US7857782Feb 5, 2009Dec 28, 2010Glaukos CorporationOcular implant delivery system and method thereof
US7862531Jun 25, 2004Jan 4, 2011Optonol Ltd.Flow regulating implants
US7867186Aug 5, 2003Jan 11, 2011Glaukos CorporationDevices and methods for treatment of ocular disorders
US7867205May 6, 2005Jan 11, 2011Glaukos CorporationMethod of delivering an implant for treating an ocular disorder
US7875048Sep 3, 2004Jan 25, 2011Spiration, Inc.One-way valve devices for anchored implantation in a lung
US7879001Aug 8, 2007Feb 1, 2011Glaukos CorporationDevices and methods for treatment of ocular disorders
US7879079Jun 19, 2006Feb 1, 2011Glaukos CorporationImplant delivery system and methods thereof for treating ocular disorders
US7887585Mar 4, 2009Feb 15, 2011Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US7896887Apr 10, 2007Mar 1, 2011Spiration, Inc.Apparatus and method for deployment of a bronchial obstruction device
US7942931Aug 15, 2005May 17, 2011Spiration, Inc.Device and method for intra-bronchial provision of a therapeutic agent
US7947008Aug 12, 2008May 24, 2011University Of SaskatchewanShunt and method treatment of glaucoma
US7951121 *Jul 30, 2003May 31, 2011Navilyst Medical, Inc.Pressure actuated valve with improved slit configuration
US7951155Jan 16, 2007May 31, 2011Glaukos CorporationCombined treatment for cataract and glaucoma treatment
US8007459Dec 18, 2008Aug 30, 2011Glaukos CorporationOcular implant with anchoring mechanism and multiple outlets
US8012115Apr 7, 2008Sep 6, 2011S.K. Pharmaceuticals, Inc.Optic nerve implants
US8021385Jul 19, 2007Sep 20, 2011Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8034016Dec 7, 2007Oct 11, 2011Optonol, Ltd.Flow regulating implants and methods of implanting
US8043301Apr 10, 2009Oct 25, 2011Spiration, Inc.Valve loader method, system, and apparatus
US8062244Feb 5, 2009Nov 22, 2011Glaukos CorporationSelf-trephining implant and methods thereof for treatment of ocular disorders
US8075511Apr 28, 2008Dec 13, 2011Glaukos CorporationSystem for treating ocular disorders and methods thereof
US8079368Mar 10, 2010Dec 20, 2011Spiration, Inc.Bronchoscopic lung volume reduction method
US8109896Feb 11, 2008Feb 7, 2012Optonol Ltd.Devices and methods for opening fluid passageways
US8118768Oct 6, 2008Feb 21, 2012Dose Medical CorporationDrug eluting ocular implant with anchor and methods thereof
US8128588 *Dec 22, 2006Mar 6, 2012Transcend Medical, Inc.Ocular pressure regulation
US8136230Oct 10, 2008Mar 20, 2012Spiration, Inc.Valve loader method, system, and apparatus
US8136520Jan 14, 2010Mar 20, 2012Pulmonx CorporationOcclusion device
US8142364Jan 4, 2010Mar 27, 2012Dose Medical CorporationMethod of monitoring intraocular pressure and treating an ocular disorder
US8152752Nov 12, 2004Apr 10, 2012Glaukos CorporationShunt device and method for treating glaucoma
US8167939Sep 26, 2011May 1, 2012Transcend Medical, Inc.Ocular implant with stiffness qualities, methods of implantation and system
US8172899Sep 26, 2011May 8, 2012Transcend Medical, Inc.Ocular implant with stiffness qualities, methods of implantation and system
US8177805Aug 4, 2011May 15, 2012Spiration, Inc.Removable anchored lung volume reduction devices and methods
US8187234Jan 29, 2004May 29, 2012Navilyst Medical, Inc.Pressure activated safety valve with anti-adherent coating
US8206684Feb 25, 2005Jun 26, 2012Pulmonx CorporationMethods and devices for blocking flow through collateral pathways in the lung
US8246569 *Aug 16, 2005Aug 21, 2012California Institute Of TechnologyImplantable intraocular pressure drain
US8251067Aug 16, 2010Aug 28, 2012Pulmonx CorporationBronchial flow control devices with membrane seal
US8257321May 21, 2008Sep 4, 2012Navilyst Medical, Inc.Pressure activated valve for high flow rate and pressure venous access applications
US8257381Dec 15, 2010Sep 4, 2012Spiration, Inc.One-way valve devices for anchored implantation in a lung
US8262726Oct 5, 2010Sep 11, 2012Transcend Medical, Inc.Ocular implant with stiffness qualities, methods of implantation and system
US8267882Mar 5, 2009Sep 18, 2012Ivantis, Inc.Methods and apparatus for treating glaucoma
US8273050Jul 12, 2004Sep 25, 2012Glaukos CorporationOcular implant with anchor and therapeutic agent
US8277418Nov 22, 2010Oct 2, 2012Alcon Research, Ltd.Ophthalmic valved trocar cannula
US8282592May 6, 2010Oct 9, 2012Ivantis, Inc.Glaucoma treatment method
US8308701Nov 15, 2010Nov 13, 2012Aquesys, Inc.Methods for deploying intraocular shunts
US8313454 *Mar 26, 2010Nov 20, 2012Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
US8328768Feb 11, 2005Dec 11, 2012Angiodynamics, IncPressure activated safety valve with improved flow characteristics and durability
US8333742May 7, 2009Dec 18, 2012Glaukos CorporationMethod of delivering an implant for treating an ocular disorder
US8337445Sep 25, 2007Dec 25, 2012Glaukos CorporationOcular implant with double anchor mechanism
US8337470Jan 28, 2009Dec 25, 2012Angiodynamics, Inc.Three-way valve for power injection in vascular access devices
US8343106Nov 22, 2010Jan 1, 2013Alcon Research, Ltd.Ophthalmic valved trocar vent
US8348877May 3, 2010Jan 8, 2013Dose Medical CorporationOcular implant with therapeutic agents and methods thereof
US8353856Nov 5, 2008Jan 15, 2013Abbott Medical Optics Inc.Glaucoma drainage shunts and methods of use
US8357139Nov 4, 2008Jan 22, 2013Pulmonx CorporationMethods and devices for use in performing pulmonary procedures
US8372026Feb 3, 2012Feb 12, 2013Ivantis, Inc.Ocular implant architectures
US8377011Aug 31, 2011Feb 19, 2013Angiodynamics, Inc.Pressure activated valve with high flow slit
US8377122Jan 27, 2010Feb 19, 2013Transcend Medical, Inc.Ocular implant with stiffness qualities, methods of implantation and system
US8382664 *Oct 27, 2011Feb 26, 2013Applied Medical Technology, Inc.Molded and undivided medical penetrating device
US8388568May 7, 2009Mar 5, 2013Glaukos CorporationShunt device and method for treating ocular disorders
US8388682Jun 22, 2010Mar 5, 2013Pulmonx CorporationBronchial flow control devices and methods of use
US8414518Mar 21, 2012Apr 9, 2013Ivantis, Inc.Glaucoma treatment method
US8414655Jul 1, 2010Apr 9, 2013Spiration, Inc.Removable lung reduction devices, systems, and methods
US8425449Jul 9, 2010Apr 23, 2013Ivantis, Inc.Ocular implants and methods for delivering ocular implants into the eye
US8444588Feb 23, 2010May 21, 2013Transcend Medical, Inc.Internal shunt and method for treating glaucoma
US8444690Jan 12, 2011May 21, 2013Spiration, Inc.Bronchoscopic repair of air leaks in a lung
US8454574Apr 30, 2012Jun 4, 2013Navilyst Medical, Inc.Pressure activated safety valve with grooved membrane
US8454708Apr 5, 2010Jun 4, 2013Spiration, Inc.Articulable anchor
US8474460Sep 17, 2010Jul 2, 2013Pulmonx CorporationImplanted bronchial isolation devices and methods
US8486000 *Nov 12, 2004Jul 16, 2013Transcend Medical, Inc.Ocular pressure regulation
US8486086Nov 7, 2011Jul 16, 2013Optonol, LtdFlow regulating implant, method of manufacture, and delivery device
US8506515 *Nov 9, 2007Aug 13, 2013Glaukos CorporationUveoscleral shunt and methods for implanting same
US8512404Nov 20, 2007Aug 20, 2013Ivantis, Inc.Ocular implant delivery system and method
US8523821Nov 23, 2011Sep 3, 2013Navilyst Medical, IncPower injection valve
US8529492Dec 20, 2010Sep 10, 2013Trascend Medical, Inc.Drug delivery devices and methods
US8529494Sep 11, 2012Sep 10, 2013Ivantis, Inc.Methods and apparatus for treating glaucoma
US8529523Oct 14, 2008Sep 10, 2013Navilyst Medical, Inc.Pressure actuated valve with improved biasing member
US8540685Nov 16, 2011Sep 24, 2013Navilyst Medical, Inc.Valved catheters including high flow rate catheters
US8551166Nov 19, 2012Oct 8, 2013Ivantis, Inc.Methods and apparatus for delivering ocular implants into the eye
US8574294Dec 16, 2010Nov 5, 2013Transcend Medical, Inc.Ocular implant with stiffness qualities, methods of implantation and system
US8579846Nov 21, 2011Nov 12, 2013Glaukos CorporationOcular implant systems
US8585629Dec 8, 2011Nov 19, 2013Aquesys, Inc.Systems for deploying intraocular shunts
US8585630 *Jul 23, 2012Nov 19, 2013California Institute Of TechnologyImplantable intraocular pressure drain
US8585660Jan 25, 2006Nov 19, 2013Navilyst Medical, Inc.Valved catheter with power injection bypass
US8617094Jan 12, 2006Dec 31, 2013Glaukos CorporationFluid infusion methods for glaucoma treatment
US8617139Jun 25, 2009Dec 31, 2013Transcend Medical, Inc.Ocular implant with shape change capabilities
US8647392Apr 26, 2012Feb 11, 2014Spiration, Inc.Articulable anchor
US8657776Jun 14, 2011Feb 25, 2014Ivantis, Inc.Ocular implants for delivery into the eye
US8663150Dec 19, 2011Mar 4, 2014Ivantis, Inc.Delivering ocular implants into the eye
US8663303Nov 15, 2010Mar 4, 2014Aquesys, Inc.Methods for deploying an intraocular shunt from a deployment device and into an eye
US8667973Nov 1, 2011Mar 11, 2014Spiration, Inc.Bronchoscopic lung volume reduction method
US8672870Jul 17, 2008Mar 18, 2014Transcend Medical, Inc.Ocular implant with hydrogel expansion capabilities
US8679064Aug 13, 2012Mar 25, 2014Alcon Research, Ltd.Ophthalmic valved trocar cannula
US8679074Jun 21, 2011Mar 25, 2014Angiodynamics, Inc.Pressure responsive slit valve assembly for a plurality of fluids and uses thereof
US8702639Mar 25, 2010Apr 22, 2014Abbott Medical Optics Inc.Glaucoma shunts with flow management and improved surgical performance
US8721656Dec 22, 2006May 13, 2014Transcend Medical, Inc.Glaucoma treatment device
US8721702Nov 15, 2010May 13, 2014Aquesys, Inc.Intraocular shunt deployment devices
US8728021Dec 17, 2010May 20, 2014Transcend Medical, Inc.Ocular pressure regulation
US8734377Sep 23, 2008May 27, 2014Ivantis, Inc.Ocular implants with asymmetric flexibility
US8734378Sep 17, 2009May 27, 2014Transcend Medical, Inc.Glaucoma treatment device
US8753320Jul 5, 2011Jun 17, 2014Navilyst Medical, Inc.Method to secure an elastic component in a valve
US8758289Dec 17, 2010Jun 24, 2014Transcend Medical, Inc.Ocular pressure regulation
US8758290Dec 23, 2011Jun 24, 2014Aquesys, Inc.Devices and methods for implanting a shunt in the suprachoroidal space
US8765210Dec 8, 2011Jul 1, 2014Aquesys, Inc.Systems and methods for making gelatin shunts
US8771217 *Dec 13, 2010Jul 8, 2014Glaukos CorporationShunt device and method for treating ocular disorders
US8771218Dec 17, 2010Jul 8, 2014Transcend Medical, Inc.Ocular pressure regulation
US8795241May 13, 2011Aug 5, 2014Spiration, Inc.Deployment catheter
US8801648Feb 5, 2009Aug 12, 2014Glaukos CorporationOcular implant with anchor and methods thereof
US8801649Oct 5, 2010Aug 12, 2014Transcend Medical, Inc.Glaucoma treatment device
US8801766Nov 15, 2010Aug 12, 2014Aquesys, Inc.Devices for deploying intraocular shunts
US8808219Feb 5, 2009Aug 19, 2014Glaukos CorporationImplant delivery device and methods thereof for treatment of ocular disorders
US8808220Oct 14, 2010Aug 19, 2014Transcend Medical, Inc.Ocular pressure regulation
US8808222Aug 22, 2013Aug 19, 2014Ivantis, Inc.Methods and apparatus for delivering ocular implants into the eye
US8814819Dec 16, 2010Aug 26, 2014Transcend Medical, Inc.Glaucoma treatment device
US8814820Sep 20, 2012Aug 26, 2014Glaukos CorporationOcular implant with therapeutic agent and methods thereof
US8828070Nov 15, 2010Sep 9, 2014Aquesys, Inc.Devices for deploying intraocular shunts
US20100174272 *Dec 18, 2009Jul 8, 2010Weiner Alan LIn-situ refillable ophthalmic implant
US20100274259 *Mar 26, 2010Oct 28, 2010Optonol Ltd.Fluid drainage device, delivery device, and associated methods of use and manufacture
US20110196281 *Dec 13, 2010Aug 11, 2011Glaukos CorporationShunt device and method for treating ocular disorders
US20110282456 *Feb 5, 2010Nov 17, 2011Newvert Ltd.Implantable device for sealing a spinal annular fissure tear and method for deploying the same
US20120041270 *Oct 27, 2011Feb 16, 2012Applied Medical Technology, Inc.Molded and undivided medical penetrating device
EP0102747A1 *Jul 28, 1983Mar 14, 1984Thomas C. WhiteOcular pressure relief device
EP0228185A1 *Nov 26, 1986Jul 8, 1987Thomas C. WhiteTissue-implantable fluid-dissipating device
EP0967946A1 *Nov 28, 1997Jan 5, 2000The Lions Eye Institute of Western Australia IncorporatedBiological microfistula tube and implantation method and apparatus
EP1184010A2 *Aug 29, 2001Mar 6, 2002Aixmed Gesellschaft für Medizintechnik mbHAqueous humour drainage device
EP1418868A2 *Apr 8, 2002May 19, 2004Glaukos CorporationGlaucoma stent and methods thereof for glaucoma treatment
EP1473004A2May 13, 1996Nov 3, 2004Optonol Ltd.Ophtalmic implant for treating glaucoma and delivery device
EP1477146A2 *Apr 26, 2000Nov 17, 2004Gmp Vision Solutions, Inc.Shunt device and method for treating glaucoma
EP1596902A2 *Feb 18, 2004Nov 23, 2005Hampar KarageozianMethods and devices for draining fluids and lowering intraocular pressure
EP2319469A1Nov 18, 1998May 11, 2011Optonol Ltd.Flow regulating implant, method of manufacturing, and delivery device
WO1989000869A1 *Aug 8, 1988Feb 9, 1989Thomas C WhiteGlaucoma drainage in the lacrimal system
WO1993003778A1 *Aug 14, 1992Mar 4, 1993Francis W Price JrEye filtration prosthesis for relieving intraocular pressure
WO1996018357A2 *Dec 7, 1995Jun 20, 1996F Barry BaysValve assembly and method for relieving synovial fluid pressure
WO1999008741A1 *Aug 19, 1998Feb 25, 1999Abbeymoor Medical IncUrethral device with anchoring system
WO2000064391A1 *Apr 26, 2000Nov 2, 2000Reay H BrownStent device and method for treating glaucoma
WO2000064393A1 *Apr 26, 2000Nov 2, 2000Reay H BrownShunt device and method for treating glaucoma
WO2002070045A1 *Jan 9, 2002Sep 12, 2002J David BrownGlaucoma treatment device and method
WO2002080811A2 *Apr 8, 2002Oct 17, 2002Glaukos CorpGlaucoma stent and methods thereof for glaucoma treatment
WO2004062469A2 *Jan 5, 2004Jul 29, 2004Clarity CorpSinus valved glaucoma shunt
WO2005016418A1 *Aug 3, 2004Feb 24, 2005Glaukos CorpDevices and methods for glaucoma treatment
WO2005046782A1 *Nov 12, 2004May 26, 2005Minas Theodore CoroneoOcular pressure regulation
WO2005122980A1 *Jun 10, 2005Dec 29, 2005Savage JamesApparatus and method for non-pharmacological treatment of glaucoma and lowering intraocular pressure
WO2010126076A1 *Apr 28, 2010Nov 4, 2010Mani,Inc.Cannula for ophthalmic surgery and method of manufacturing same
Classifications
U.S. Classification604/247, 604/175, 604/9
International ClassificationA61B5/07, A61F9/007, A61B3/16
Cooperative ClassificationA61B3/16, A61B5/076, A61F9/00781
European ClassificationA61F9/007V, A61B5/07D, A61B3/16